Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) “Prevention of Relapse of Multiple Sclerosis”
Condition(s):Multiple SclerosisLast Updated:December 29, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:December 29, 2023Active, not recruiting
Condition(s):Cutaneous Squamous Cell Carcinoma; Squamous Cell Carcinoma; Basal Cell CarcinomaLast Updated:May 19, 2023Active, not recruiting
Condition(s):Rett SyndromeLast Updated:November 5, 2018Completed
Condition(s):Multiple SclerosisLast Updated:October 17, 2013Completed
Condition(s):Relapsing-Remitting Multiple SclerosisLast Updated:February 18, 2020Completed
Condition(s):Relapsing-Remitting Multiple SclerosisLast Updated:April 2, 2014Terminated
Condition(s):Multiple SclerosisLast Updated:February 10, 2010Unknown status
Condition(s):Multiple SclerosisLast Updated:December 9, 2021Completed
Condition(s):Relapse Remitting Multiple SclerosisLast Updated:April 12, 2011Completed
Condition(s):Relapsing Remitting Multiple SclerosisLast Updated:October 10, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.